SCHEMBL7222765

SCHEMBL7222765

COc1ccc([C](C#N)C#N)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 11/20 0.61
PDE4A P27815 10/20 0.61
PDE4C Q08493 10/20 0.61
PDE4D Q08499 10/20 0.61
ELANE P08246 1/20 0.57
CYP2C9 P11712 2/20 0.57
CYP2C19 P33261 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
TSHR P16473 1/20 0.57
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA4 P22748 1/20 0.55
CA6 P23280 1/20 0.55
CA7 P43166 1/20 0.55
TPMT P51580 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
ALDH1A1 P00352 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976684 0.81 CYP1A2 (0.63) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL30413049 0.81 CYP1A2 (0.63) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL1981893 0.79 HPGD (0.57) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL5073571 0.79 TSHR (0.56) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL11823844 0.79 PDE4A (0.56) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL30104252 0.78 PDE4B (0.58) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL7781767 0.78 PDE4A (0.54) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL4255573 0.78 PDE4A (0.54) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL7781768 0.78 PDE4A (0.54) PDE4BPDE4APDE4CPDE4DELANE
SCHEMBL7512362 0.77 CYP1A2 (0.58) PDE4BPDE4APDE4CPDE4DELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6531612-B2 Pyrrolidine-2-carboxylic acid cyano-methyl amide derivatives useful for treating diseases associated with cystein proteases, such as osteoporosis, osteoarthritis, rheumatoid arthritis, tumor metastasis, glomerulonephritis HOFFMAN-LA ROCHE INC. 2003-03-11 US disclosed